Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 17/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formestane SCHEMBL3230067 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| Formestane SCHEMBL14291425 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| Formestane SCHEMBL22891821 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| Formestane SCHEMBL13838287 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| Formestane SCHEMBL13795108 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| Formestane SCHEMBL947479 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| SCHEMBL10942772 | 0.90 | CYP3A4 (0.81) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| SCHEMBL10942767 | 0.90 | CYP3A4 (0.81) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| Formestane SCHEMBL27563770 | 0.88 | CYP19A1 (0.77) | CYP3A4TSHRTHPOHIF1ATDP1 | |
| SCHEMBL7739598 | 0.87 | CYP3A4 (0.77) | CYP3A4TSHRTHPOHIF1ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 31956 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| EP-3645742-B1 | ANTI-ROR1 ANTIBODIES AND METHODS OF MAKING AND USING THEREOF | SYSTIMMUNE INC (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260103461-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | OLEMA PHARMACEUTICALS INC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4712980-A1 | TREATMENT OF BREAST TISSUE | Havah Therapeutics Pty Ltd (AU) | 2026-03-25 | — | — | EP | claimed |
| EP-4680251-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | Thomas Jefferson University (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4680284-A2 | BIODEGRADABLE DENDRITIC PARTICLES FOR SUSTAINED DRUG RELEASE | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2026-01-21 | — | — | EP | claimed |
| EP-4680226-A2 | ACYLSULFONAMIDE KAT6A INHIBITORS | Olema Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| US-5002940-A | Steroids, Phospholipids, Polyoxyethylene Glycol | CIBA-GEIGY CORPORATION (US) | 1991-03-26 | — | — | US | claimed |
| WO-1991000731-A1 | COMBINATION THERAPY FOR PROPHYLAXIS AND/OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | ENDORECHERCHE INC. (CA) | 1991-01-24 | — | — | WO | claimed |
| WO-1990010462-A1 | COMBINATION THERAPY FOR TREATMENT OF ESTROGEN SENSITIVE DISEASES | ENDORECHERCHE INC. (CA) | 1990-09-20 | — | — | WO | claimed |
| EP-0181287-B1 | DRY SUBSTANCES AND STABLE SUSPENSIONS | CIBA-GEIGY AG (CH) | 1990-03-21 | — | — | EP | claimed |
| US-4895715-A | Method of treating gynecomastia | SCHERING CORPORATION (US) | 1990-01-23 | — | — | US | claimed |
| US-4749567-A | WITH 6-HYDROXYANDROST-4-ENE-3, 17-DIONE, LINKED THROUGH THE HYDROXY | THE DIRECTOR GENERAL OF THE MINISTRY OF AGRICULTURE AND FISHERIES (NZ) | 1988-06-07 | — | — | US | claimed |
| US-4598072-A | Combinations of an aromatase-inhibitor and an antiandrogen for prophylaxis and/or treatment of benign prostatic hyperplasia | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | claimed |
| US-4596797-A | Urogenital disorders | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-06-24 | — | — | US | claimed |
| EP-0181287-A2 | Dry substances and stable suspensions | CIBA-GEIGY AG (CH) | 1986-05-14 | — | — | EP | claimed |
| US-4500523-A | Suppression of premature labor by use of aromatase inhibitors | CORNELL RESEARCH FOUNDATION, INC. (US) | 1985-02-19 | — | — | US | claimed |